Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CD103+ T and Dendritic Cells Indicate a Favorable Prognosis in Oral Cancer
Xiao Yang, Hao Li, Liang Mao, et al.
Journal of Dental Research (2019) Vol. 98, Iss. 13, pp. 1480-1487
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment
Ayana T. Ruffin, Housaiyin Li, Lazar Vujanović, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 3, pp. 173-188
Open Access | Times Cited: 165
Tumor Infiltrating Lymphocyte (TIL) Therapy for Solid Tumor Treatment: Progressions and Challenges
Yueshui Zhao, Jian Deng, Shuangfeng Rao, et al.
Cancers (2022) Vol. 14, Iss. 17, pp. 4160-4160
Open Access | Times Cited: 109
Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis
Hina Qayoom, Shazia Sofi, Manzoor Ahmad Mir
Immunologic Research (2023) Vol. 71, Iss. 4, pp. 588-599
Closed Access | Times Cited: 43
Fn-OMV potentiates ZBP1-mediated PANoptosis triggered by oncolytic HSV-1 to fuel antitumor immunity
Shuo Wang, An Song, Jun Xie, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21
Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully
Baisheng Lin, Likun Du, Hongmei Li, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 132, pp. 110873-110873
Open Access | Times Cited: 137
GSDME Is Related to Prognosis and Response to Chemotherapy in Oral Cancer
Shuo Wang, Master Jingwen Zhang, Zhi‐Zhong Wu, et al.
Journal of Dental Research (2022) Vol. 101, Iss. 7, pp. 848-858
Closed Access | Times Cited: 51
A comprehensive profile of TCF1+ progenitor and TCF1− terminally exhausted PD-1+CD8+ T cells in head and neck squamous cell carcinoma: implications for prognosis and immunotherapy
Dikan Wang, Juan Fang, Shuqiong Wen, et al.
International Journal of Oral Science (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 40
CTLA-4 blockade induces tumor pyroptosis via CD8+ T cells in head and neck squamous cell carcinoma
Shuo Wang, Zhi‐Zhong Wu, Su‐Wen Zhu, et al.
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 2154-2168
Closed Access | Times Cited: 27
Isolation of tumour-reactive lymphocytes from peripheral blood via microfluidic immunomagnetic cell sorting
Zongjie Wang, Sharif Ahmed, Mahmoud Labib, et al.
Nature Biomedical Engineering (2023) Vol. 7, Iss. 9, pp. 1188-1203
Closed Access | Times Cited: 27
Targeting oral tumor microenvironment for effective therapy
Hendrik Setia Budi, Bagher Farhood
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Investigating Tumor-Infiltrating Lymphocytes in the Microenvironment of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorders (OPMDs): Can They Shift Our Perspective? A Scoping Review
Samuele Sutera, Olga Anna Furchì, Monica Pentenero
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 606-606
Open Access | Times Cited: 1
Mechanism of tumour microenvironment in the progression and development of oral cancer
Mohd Mughees, Anindita Sengupta, Sapna Khowal, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 2, pp. 1773-1786
Closed Access | Times Cited: 33
Tissue-resident memory CD8+ T cells in cancer immunology and immunotherapy
Ting Wang, Yifei Shen, Sophia Luyten, et al.
Pharmacological Research (2020) Vol. 159, pp. 104876-104876
Closed Access | Times Cited: 39
Long Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma
Hao Li, Hong‐Gang Xiong, Yao Xiao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 38
A ferroptosis-related prognostic model with excellent clinical performance based on the exploration of the mechanism of oral squamous cell carcinoma progression
Xin Fan, Yun Zhong, Fang Yuan, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Metformin switches cell death modes to soothe the apical periodontitis via ZBP1
Hui Liu, Y.-R. Liu, Wei Fan, et al.
The FASEB Journal (2024) Vol. 38, Iss. 5
Closed Access | Times Cited: 4
VISTA blockade alleviates immunosuppression of MDSCs in oral squamous cell carcinoma
Jie Liu, Wen‐Ping Lin, Yao Xiao, et al.
International Immunopharmacology (2023) Vol. 125, pp. 111128-111128
Closed Access | Times Cited: 10
Tissue‐resident memory T cells in diseases and therapeutic strategies
Daoyuan Xie, Guanting Lu, Gang Mai, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Disulfidptosis-related immune patterns predict prognosis and characterize the tumor microenvironment in oral squamous cell carcinoma
Xuechen Wu, Boxin Liu, Shi‐Zhou Deng, et al.
BMC Oral Health (2025) Vol. 25, Iss. 1
Open Access
Tissue-resident memory T-cell expressions and their prognostic role in head and neck squamous cell carcinoma: a systematic review and meta-analysis
Anwar Ali, Muhammad Furqan Bari, Saba Arshad, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Optimization of Immunotherapy Strategies Based on Spatiotemporal Heterogeneity of Tumour‐Associated Tissue‐Resident Memory T Cells
Yongheng Shang, Yinjun He, Xiang Zhang, et al.
Immunology (2025)
Closed Access
Immune profiling identifies CD8+ T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer
Zhen Chen, Mengli Guo, Ya-yi Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
CMTM4 regulates epithelial–mesenchymal transition and PD‐L1 expression in head and neck squamous cell carcinoma
Hao Li, Yuan‐Tong Liu, Lei Chen, et al.
Molecular Carcinogenesis (2021) Vol. 60, Iss. 8, pp. 556-566
Closed Access | Times Cited: 19
Pembrolizumab and cabozantinib in recurrent and/or metastatic head and neck squamous cell carcinoma (RMHNSCC): long-term survival update with a biomarker analysis
Nabil F. Saba, Ritu Chaudhary, Kedar Kirtane, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 20, pp. 4601-4608
Closed Access | Times Cited: 2
Immunology of Oral Squamous Cell Carcinoma—A Comprehensive Insight with Recent Concepts
Sowmya Samudrala Venkatesiah, Dominic Augustine, Deepika Mishra, et al.
Life (2022) Vol. 12, Iss. 11, pp. 1807-1807
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top